May
07
MycoDev Receives $500K in Venture Capital Investment
ByNBIF today announced a $500,000 venture capital investment in MycoDev Group Inc. MycoDev’s main product, a biopolymer called chitosan, is highly sought after by a wide variety of industries, especially the pharmaceutical and medical device industries.
“Chitosan is an extremely effective coagulant that, when combined with other agents, can almost immediately stop bleeding and promote healing in humans,” says NBIF CEO Calvin Milbury, “although chitosan is already on the market, its traditional production method leaves impurities that can prevent its use in pharmaceutical products.”…